The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

Launched by SIRIRAJ HOSPITAL · May 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two treatment options for women experiencing female pattern hair loss, a common condition that can cause thinning hair. The researchers want to find out which treatment works better and is safer: platelet-rich fibrin or platelet-rich plasma. Both of these treatments use components from your own blood to help promote hair growth.

To participate in this trial, you need to be a woman between the ages of 20 and 55 who has been diagnosed with a specific type of hair loss by a dermatologist. However, if you are pregnant, have certain medical conditions, or take specific medications, you might not be eligible. If you join the study, you will be randomly assigned to receive either platelet-rich fibrin or platelet-rich plasma, and you can expect regular check-ups to monitor your progress and ensure your safety. This trial is currently recruiting participants, so it’s a great opportunity to explore potential treatment for hair loss.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 20-55 years
• • Female
• • Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist
• Exclusion Criteria:
• • Pregnancy or Lactation subjects
• • Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host
• • Subject who are active smoking and alcoholism
• • Subject who has dermatitis, scar or infection at intervention area
• • Subject who has history of allergy to anesthesia drug
• • Subject who taking NSAIDs, Hormonal drug, anticoagulants drug
• • Subject who has psychiatric condition diagnosed by psychiatrist
• • Subject who are not allowed to take a photo

Trial Officials